ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3451
0,00%
Bitcoin
69.248,01
-0,08%
Brent Oil
79,395
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) Notícias

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SEEL
DataHoraFonteTítuloCódigoCompanhia
05/06/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
31/05/202417:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
20/05/202417:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
14/05/202409:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202419:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
06/03/202418:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
01/03/202419:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
06/02/202419:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
02/02/202408:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
02/01/202410:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
28/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
18/12/202318:54Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
15/12/202318:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
04/12/202318:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
28/11/202318:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SEELSeelos Therapeutics Inc
29/06/202310:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SEELSeelos Therapeutics Inc
12/05/202317:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SEELSeelos Therapeutics Inc
28/04/202307:23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202317:11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202318:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SEELSeelos Therapeutics Inc
31/03/202317:09Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SEELSeelos Therapeutics Inc
13/03/202317:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SEELSeelos Therapeutics Inc
10/03/202308:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SEELSeelos Therapeutics Inc
09/02/202314:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SEELSeelos Therapeutics Inc
08/07/202217:59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SEELSeelos Therapeutics Inc
04/05/202208:35TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Masimo (MASI)NASDAQ:SEELSeelos Therapeutics Inc
12/04/202218:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SEELSeelos Therapeutics Inc
11/03/202214:05TipRanksAnalysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Leap Therapeutics (LPTX)NASDAQ:SEELSeelos Therapeutics Inc
24/01/202206:50TipRanksB.Riley Financial Thinks Seelos Therapeutics’ Stock is Going to RecoverNASDAQ:SEELSeelos Therapeutics Inc
27/12/202119:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SEELSeelos Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SEEL

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados